Genomic and transcriptomic analyses reveal a tandem amplification unit of 11 genes and mutations in mismatch repair genes in methotrexate-resistant HT-29 cells

Exp Mol Med. 2021 Sep;53(9):1344-1355. doi: 10.1038/s12276-021-00668-x. Epub 2021 Sep 14.

Abstract

DHFR gene amplification is commonly present in methotrexate (MTX)-resistant colon cancer cells and acute lymphoblastic leukemia. In this study, we proposed an integrative framework to characterize the amplified region by using a combination of single-molecule real-time sequencing, next-generation optical mapping, and chromosome conformation capture (Hi-C). We identified an amplification unit spanning 11 genes, from the DHFR gene to the ATP6AP1L gene position, with high adjusted interaction frequencies on chromosome 5 (~2.2 Mbp) and a twenty-fold tandemly amplified region, and novel inversions at the start and end positions of the amplified region as well as frameshift insertions in most of the MSH and MLH genes were detected. These mutations might stimulate chromosomal breakage and cause the dysregulation of mismatch repair. Characterizing the tandem gene-amplified unit may be critical for identifying the mechanisms that trigger genomic rearrangements. These findings may provide new insight into the mechanisms underlying the amplification process and the evolution of drug resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing
  • Biomarkers, Tumor
  • Chromosome Mapping
  • DNA Mismatch Repair*
  • Drug Resistance, Neoplasm / genetics*
  • Gene Amplification*
  • Gene Expression Regulation, Neoplastic
  • Genomics* / methods
  • HT29 Cells
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Methotrexate / pharmacology
  • Mutation*
  • Tandem Repeat Sequences*
  • Transcriptome*

Substances

  • Biomarkers, Tumor
  • Methotrexate